Chemotherapy Foundation Symposium XXVI: Innovative cancer therapy for tomorrow - Chronic myelogenous leukemia: Is there hope after therapeutic failure with imatinib (Gleevec)?

Marvin M. Goldenberg, Jorges Cortes

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Chemotherapy Foundation Symposium XXVI: Innovative cancer therapy for tomorrow - Chronic myelogenous leukemia: Is there hope after therapeutic failure with imatinib (Gleevec)?'. Together they form a unique fingerprint.

Medicine & Life Sciences